Hypoglycemic, antioxidant and antihyperlipidemic effects of the aqueous sepal extracts of Salmalia malabarica in streptozotocin-induced diabetic rat

Ethiopian Pharmaceutical Journal

Volumn 27, Issue 1, 2009, Pages 1-15

  Ali, Kazi Monjur ^a   Chatterjee, Kausik ^a   De, Debasis ^a   Bera, Tushar Kanti ^a   Mallick, Chhanda ^a   Ghosh, Debidas ^a  

^a VIDYASAGAR UNIVERSITY   (India)

Author keywords

Antihyperlipidemic; Antioxidative; Hypoglycemic; Salmalia malabarica; Sepals

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKADIENE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMINE PHENYLPYRUVATE AMINOTRANSFERASE; GLUTATHIONE TRANSFERASE; GLYCOGEN; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PEROXIDASE; PLANT EXTRACT; SALMALIA MALABARICA EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERLIPIDEMIA; KIDNEY; LIPID BLOOD LEVEL; LIVER; LIVER METABOLISM; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; RAT; SALMALIA MALABARICA; SEPAL; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TISSUE LEVEL; TOXICITY TESTING;

EID: 78249280819     PISSN: 10295933     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974). Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
2. Baily CJ, Day C (1989). Traditional medicines in the treatment of diabetes. Diabetes Care 12: 553-564.
3. Balkau B, Charles MA, Eschwege E (2000). Epidemiological discourse on new criteria on diabetes. Mol Endocrinol 2: 229-234.
4. Barik R, Jain S, Qwatra D, Joshi A, Tripathi GS, Goyal R (2008). Antidiabetic activity of aqueous root extract of Ichnocarpus frutescens in streptozotocin-nicotinamide induced type-2 diabetes in rats. Indian J Pharmacol 40: 19-22. (Pubitemid 351600808)
5. Baynes JW (1991). Role of oxidative stress in the development of complications in diabetes. Diabetes 40: 405-412.
6. Beers RF, Sizer IW (1952). A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195: 133-140.
7. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H (2002). Pharmacokinetics and bioavailability of herbal medicinal products. Phytomed 9 (Supp.): 1-33.
8. Chou AC, Wilson JE (1975). Carbohydrate metabolism. In: Wood WA ed, Methods in Enzymology, vol. XIII, New York, Academic Press, pp 20-21.
9. Desai SA, Mani UV, Lyer UM (2002). Serum lipids, apolipoproteins and total antioxidant activity levels of obese, diabetic and hypertensive subjects in an industrial set up in Baroda, Gujarat, India. Int J Diab Dev Countries 22: 91-99.
10. Djrolo F, Houngbe H, Avode G, Addra B, Kodjoh N, Avinadje M, Monterio B (1998). Malnutrition related diabetes (tropical diabetes). Med Afrique Noire 45: 538-542.
11. El-Beshbishy HA, Singab ANB, Sinkkonen J, Pihlaja K (2006). Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci 78: 2724-2733.
12. Friedewald WT, Levy RI, Frederickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
13. th edn, Kolkata, pp 178-180.
14. Habig WH, Pabst MJ, Jakoby WB (1974). Glutathione-S-tranferases; the first step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
15. Henry RJ, Chiamori M, Golub OJ, Berkman S (1960). Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol 34: 381-398.
16. Khare CP (2004). Salmalia malabarica (DC) Schott & Endl, Indian Medicinal Plants. Springer, pp 573-574.
17. Langdon RG (1966). Glucose-6-phosphate dehydrogenase from erythrocytes. In: Wood WA, ed, Methods in Enzymology, vol IX, New York, Academic Press, pp 126-131.
18. Lenzen S (2008). The mechanisms of alloxanand streptozotocin-induced diabetes. Diabetologia 51: 216-226.
19. Loew D, Kaszkin M (2002). Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 16: 705-711.
20. Lyra R, Oliveira M, Lins D, Cavalcanti N (2006). Prevention of type 2 diabetes mellitus. Arq Bras Endocrinol Metab 50: 239-249.
21. Maiti R, Jana D, Das UK, Ghosh D (2004). Anti diabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol 92: 85-91.
22. Maiti R, Das UK, Ghosh D (2005). Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol Pharm Bull 28: 1172-1176. (Pubitemid 41327580)
23. Mallick C, Maiti R, Ghosh D (2006). Comparative study on antihyperglycaemic and antihyperlipidemic effect of separate and composite extract of seed of Eugenia jambolana and root of Musa paradisiaca in streptozotocin-induced diabetic male albino rat. Ir J Pharmacol Therap 5: 27-33. (Pubitemid 351325772)
24. Mallick C, Chatterjee K, Mandal U, Ghosh D (2007). Antihyperglycemic, antilipidperoxidative and antioxidative effects of extracts of Musa paradisiaca and Coccinia indica in streptozotocin-induced diabetic rat. Ethiop Pharm J 25: 9-22.
25. Mandal S, Barik B, Mallick C, De D, Ghosh D (2008). Therapeutic effect of ferulic acid, an ethereal fraction of ethanolic extract of seed of Syzygium cumini against streptozotocin-induced diabetes in male rat. Methods Find Exp Clin Pharmacol 30: 121-128.
26. Marklund S, Marklund G (1974). Involvement of superoxide anion in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
27. McAnuff MA, Omoruyi FO, Morrison EY, Asemota HN (2003). Hepatic function enzymes and lipid peroxidation in streptozotocin-induced diabetic rats fed bitter yam (Dioscorea polygonoides) steroidal sapogenin extract. Diabetologia Croatica 32: 17-22.
28. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB (1996). Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats. J Ethnopharmacol 54: 41-46.
29. Morel DW, Chisolm GM (1989). Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834.
30. nd edn, revised, DHEW Publication (NIH), Bethesda, Maryland.
31. Okhawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
32. Palanduz S, Ademöglu E, Gökkusu C, Tamer S (2001). Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol 109: 309-318.
33. Pari L, Saravanan G (2002). Antioxidant effect of Congent db, a herbal drug in alloxan induced diabetes mellitus. Comp Biochem Physiol C Toxicol Pharmacol 131: 19-25.
34. ++. Free Rad Res 39: 707-712.
35. Prakasam A, Subramaniam S, Pugalendi KV (2003). Effect of Caseria esculenta root extract on blood glucose and plasma antioxidant status in streptozotocin diabetic rats. Polish J Pharmacol 55: 43-49. (Pubitemid 36411117)
36. Prince PSM, Menon VP, Pari L (1998). Hypoglycaemic activity of Syzygium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol 61: 1-7.
37. Pushparaj P, Tan CH, Tan BKH (2000). Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 72: 69-76.
38. rd edn, New Delhi, pp 9-10.
39. rd edn, New Delhi, pp100-101.
40. Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M (2009). Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 55: 206-214.
41. Shih KC, Kwok CF, Hwu CM, Hsiao LC, Li SH, Liu YF, Ho LT (1997). Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control. Diabetes Res Clin Pract 36: 113-119.
42. Slater TF (1984). Overview of methods used for detecting lipid peroxidation. Methods Enzymol 105: 283-293.
43. Sokal RR, Rohle FJ (1997). Biometry, WH Freeman and Company, New York, pp 179-206.
44. Soumyanath A (2006). Traditional Medicine for Modern Times: Antidiabetic Plants, CRC Press, Taylor & Francis Group, Boca Raton, p 47.
45. Swanson MA (1955). Glucose-6-phosphatase from liver. In: Colowick SP and Kaplan NO eds, Methods in Enzymology, vol II, New York, Academic Press, pp 541-543.
46. Tiwari P, Tamrakar AK, Ahmad R, Kumar R, Lakshmi V, Srivastava AK (2008). Antihyperglycemic activity of Ceriops tagal in normoglycemic and streptozotocin-induced diabetic rats. Med Chem Res 17: 74-78.
47. Waenic GR, Albers JJ (1978). A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19: 65-76.
48. Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes. Estimated for the year 2000 and projection for 2030. Diabetes Care 27: 1047-1053.